ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 262

$439K Total Retail Price of All Prescriptions

Rank: 37 out of 262

369 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 369 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,504 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LISINOPRIL 376 334 1 3
SIMVASTATIN 370 350 2 1
LEVOTHYROXINE SODIUM 271 267 3 2
FUROSEMIDE 263 251 4 4
METOPROLOL TARTRATE 251 240 5 8
AMLODIPINE BESYLATE 236 229 6 6
OMEPRAZOLE 228 211 7 5
WARFARIN SODIUM 177 163 8 12
METFORMIN HCL 176 157 9 9
METOPROLOL SUCCINATE 148 142 10 11
HYDROCHLOROTHIAZIDE 147 127 11 7
SERTRALINE HCL 146 119 12 14
GLIMEPIRIDE 138 121 13 45
ISOSORBIDE MONONITRATE ER 112 93 14 33
GABAPENTIN 111 106 15 19
LOSARTAN POTASSIUM 110 100 16 17
ALENDRONATE SODIUM 108 108 17 21
DIGOXIN 99 98 18 28
DONEPEZIL HCL 97 97 19 23
TAMSULOSIN HCL 90 83 20 25
MIRTAZAPINE 90 83 20 35
TRAZODONE HCL 89 89 22 36
HYDROCODONE-ACETAMINOPHEN 88 86 S3 23 15
CLOPIDOGREL 85 75 24 38
CARVEDILOL 84 77 25 31
POTASSIUM CHLORIDE 83 69 26 10
ALLOPURINOL 79 58 27 22
TRIAMTERENE-HCTZ 76 66 28 32
ATORVASTATIN CALCIUM 74 64 29 13
CELEBREX 71 69 30 91
VENLAFAXINE HCL ER 70 70 31 79
CITALOPRAM HBR 70 58 31 20
POLYETHYLENE GLYCOL 3350 66 54 33 42
PREDNISONE 63 61 34 29
ADVAIR DISKUS 59 47 35 34
NAMENDA 59 59 35 37
KLOR-CON 10 57 57 37 72
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 38 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 50 39 24
METFORMIN HCL ER 52 52 39 63
DOXAZOSIN MESYLATE 50 47 41 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 11, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.